Pharmacoeconomics

Journal of Association of Physicians of India

Volumn 50, Issue 8, 2002, Pages 1057-1062

  Sule, N S ^a   Nerurkar, R P ^a   Kamath, S A ^a  

^a BYL NAIR CHARITABLE HOSPITAL   (India)

Author keywords

[No Author keywords available]

Indexed keywords

COST BENEFIT ANALYSIS; DRUG COST; HUMAN; PHARMACOECONOMICS; QUALITY ADJUSTED LIFE YEAR; REVIEW;

COST-BENEFIT ANALYSIS; DRUG COSTS; ECONOMICS, PHARMACEUTICAL; HUMANS; QUALITY-ADJUSTED LIFE YEARS;

EID: 0036690035     PISSN: 00045772     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (13)

1. Schulman KA, Linas BP. Pharmacoeconomics: State of art in 1997. Annu Rev Public Health. 1997;18:529-48.
2. Haycox A, Walley T. Pharmacoeconomics: evaluating the evaluators. Br J Clin Pharmacol 1997;43:451-6.
3. Walley T, Haycox A. Pharmacoeconomics: basic concepts and terminology. Br J Clin Pharmacol 1997;43:343-8.
4. Robinson R. Economic evaluation and health care: What does it mean? BMJ 1993;307:670-3.
5. Relman AS. The new medical-industrial complex. N Engl J Med 1980;303:963-70.
6. Davey PG, Malek M, Dodd T, MacDonald T. Pharmacoeconomics and drug prescribing. In: Speight TM, Holford NHG, editors. Averys drug treatment. 14th ed. Aukland: Adis International, 1997;393-419.
7. Robinson R. Cost-effectiveness analysis. BMJ 1993;307:793-5.
8. Palmer S, Byford S, Raftery J. Economics notes: Types of economic evaluation. BMJ 1999;318:1349.
9. Behrens RH, Roberts JA. Is travel prophylaxis worthwhile? Economic appraisal of prophylactic measures against malaria, hepatitis A, and typhoid in travellers. BMJ 1994;309:918-22.
10. Robinson R. Cost benefit analysis. BMJ 1993,307:924-6.
11. Robinson R. Cost utility analysis. BMJ 1993;307:859-62.
12. Haycox A, Drummond M, Walley T. Pharmacoeconomics: imegrating economic evaluation into clinical trials. Br J Clin Pharmacol 1997;43:559-62.
13. Robinson R. Costs and cost minimisation analysis. BMJ 1993;307:726-8.